Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iSpecimen (ISPC) EBT Margin (2020 - 2025)

Historic EBT Margin for iSpecimen (ISPC) over the last 6 years, with Q3 2025 value amounting to 2654.92%.

  • iSpecimen's EBT Margin fell 25906200.0% to 2654.92% in Q3 2025 from the same period last year, while for Sep 2025 it was 366.36%, marking a year-over-year decrease of 2730900.0%. This contributed to the annual value of 138.39% for FY2024, which is 291500.0% down from last year.
  • Latest data reveals that iSpecimen reported EBT Margin of 2654.92% as of Q3 2025, which was down 25906200.0% from 255.36% recorded in Q2 2025.
  • iSpecimen's 5-year EBT Margin high stood at 48.04% for Q2 2021, and its period low was 2654.92% during Q3 2025.
  • For the 5-year period, iSpecimen's EBT Margin averaged around 256.2%, with its median value being 94.64% (2022).
  • Per our database at Business Quant, iSpecimen's EBT Margin surged by 1365400bps in 2024 and then plummeted by -25906200bps in 2025.
  • Over the past 5 years, iSpecimen's EBT Margin (Quarter) stood at 79.54% in 2021, then increased by 8bps to 72.92% in 2022, then tumbled by -51bps to 109.83% in 2023, then crashed by -270bps to 406.28% in 2024, then plummeted by -553bps to 2654.92% in 2025.
  • Its EBT Margin was 2654.92% in Q3 2025, compared to 255.36% in Q2 2025 and 154.85% in Q1 2025.